Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 18;19(7(Suppl 6)):21107.
doi: 10.7448/IAS.19.7.21107. eCollection 2016.

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa

Sybil Hosek  1 , Connie Celum  2 , Craig M Wilson  3 , Bill Kapogiannis  4 , Sinead Delany-Moretlwe  5 , Linda-Gail Bekker  6
Affiliations

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa

Sybil Hosek et al. J Int AIDS Soc. .

Abstract

Introduction: Adolescents and young adults aged <25 are a key population in the HIV epidemic, with very high HIV incidence rates in many geographic settings and a large number who have limited access to prevention services. Thus, any biomedical HIV prevention approach should prepare licensure and implementation strategies for young populations. Oral pre-exposure prophylaxis (PrEP) is the first antiretroviral-based prevention intervention with proven efficacy across many settings and populations, and regulatory and policy approvals at global and national levels are occurring rapidly. We discuss available data from studies in the United States and South Africa on the use of oral PrEP for HIV prevention in adolescent minors, along with some of the implementation challenges.

Discussion: Ongoing studies in the United States and South Africa among youth under the age of 18 should provide the safety data needed by the end of 2016 to contribute to licensure of Truvada as daily PrEP in adolescents. The challenges of completing these studies as well as foreseeable broader challenges highlighted by this work are presented. Adherence to daily PrEP is a greater challenge for younger populations, and poor adherence was associated with decreased efficacy in all PrEP trials. Individual-level barriers include limited familiarity with antiretroviral-based prevention, stigma, product storage, and social support. Structural challenges include healthcare financing for PrEP, clinician acceptability and comfort with PrEP delivery, and the limited youth-friendly health services available. These challenges are discussed in the context of the work done to date in the United States and South Africa, but will likely be magnified in the setting of limited resources in many other countries that are heavily impacted by HIV.

Conclusions: Adolescent populations are particularly vulnerable to HIV, and oral PrEP in these populations is likely to have an impact on population-level HIV incidence. The challenges of disseminating an HIV biomedical prevention tool requiring daily usage in adolescents are formidable, but addressing these issues and starting dialogues will lay the groundwork for the many other HIV prevention tools now being developed and tested.

Keywords: HIV/AIDS; PrEP; adolescents; implementation.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. WHO. Health for the world's adolescents: a second chance in the second decade. Geneva: World Health Organization; 2014.
    1. United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS. All in to #EndAdolescentAIDS: launch document [Internet] 2015. [cited 2016 July 29]. Available from: http://allintoendadolescentaids.org/wp-content/uploads/2015/02/ALL-IN-La....
    1. UNICEF. Generation 2030. Africa [Internet] 2014. [cited 2016 July 29]. Available from: http://www.unicef.org/publications/files/UNICEF_Africa_Generation_2030_e....
    1. Geier CF. Adolescent cognitive control and reward processing: implications for risk taking and substance use. Horm Behav. 2013;64(2):333–42. doi: http://dx.doi.org/10.1016/j.yhbeh.2013.02.008. - DOI - PubMed
    1. Smith AR, Chein J, Steinberg L. Impact of socio-emotional context, brain development, and pubertal maturation on adolescent risk-taking. Horm Behav. 2013;64(2):323–32. doi: http://dx.doi.org/10.1016/j.yhbeh.2013.03.006. - DOI - PMC - PubMed

Substances

LinkOut - more resources